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Abstract
Many long non-coding RNAs (lncRNAs) affect gene expression1, but the mechanisms by which 
they act are still largely unknown2. One of the best-studied lncRNAs is Xist, which is required for 
transcriptional silencing of one X-chromosome during development in female mammals3,4. 
Despite extensive efforts to define the mechanism of Xist-mediated transcriptional silencing, we 
still do not know any proteins required for this role3. The main challenge is that there are currently 
no methods to comprehensively define the proteins that directly interact with a lncRNA in the 
cell5. Here we develop a method to purify a lncRNA and identify its direct interacting proteins 
using quantitative mass spectrometry. We identify 10 proteins that specifically associate with Xist, 
three of these proteins – SHARP, SAF-A, and LBR – are required for Xist-mediated 
transcriptional silencing. We show that SHARP, which interacts with the SMRT co-repressor6 that 
activates HDAC37, is not only essential for silencing, but is also required for the exclusion of 
RNA Polymerase II (PolII) from the inactive X. Both SMRT and HDAC3 are also required for 
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silencing and PolII exclusion. In addition to silencing transcription, SHARP and HDAC3 are 
required for Xist-mediated recruitment of the polycomb repressive complex 2 (PRC2) across the 
X-chromosome. Our results suggest that Xist silences transcription by directly interacting with 
SHARP, recruiting SMRT, activating HDAC3, and deacetylating histones to exclude PolII across 
the X-chromosome.
Over the last two decades, numerous attempts have been made to define the protein 
complexes that interact with Xist and that are required for its various roles in XCI3. Most 
studies have used prior knowledge of the molecular events that occur on the X-chromosome 
to define potential Xist-interacting proteins8,9. While individual proteins have been 
identified that associate with Xist8,10, we still do not know any of the proteins required for 
Xist-mediated transcriptional silencing because perturbations of these proteins, including 
components of the PRC2 complex, have no impact on Xist-mediated transcriptional 
silencing11,12. Current methods for identifying lncRNA-interacting proteins either require 
selecting specific candidate interacting proteins or fail to distinguish between direct RNA 
interactions that occur in the cell from those that merely associate in solution (reviewed in5).
To develop a method for identifying the proteins that directly interact with a specific 
lncRNA in vivo, we adapted our RNA Antisense Purification (RAP) method13 to purify a 
lncRNA complex and identify the interacting proteins by quantitative mass spectrometry 
(RAP-MS) (Methods, Figure 1a). Briefly, RAP-MS uses UV crosslinking to create covalent 
linkages between directly interacting RNA and protein and purifies lncRNAs in denaturing 
conditions to disrupt non-covalent interactions (Methods). This UV-crosslinking and 
denaturing approach, which is utilized by methods such as CLIP, is known to identify only 
direct RNA-protein interactions and to separate interactions that are crosslinked in the cell 
from those that merely associate in solution5,14.
Adapting this UV-crosslinking and denaturing approach to enable purification of a specific 
lncRNA is challenging for several reasons: (i) In order to purify lncRNA complexes in 
denaturing conditions, we need an RNA capture method that can withstand harsh denaturing 
conditions. (ii) In order to detect the proteins associated with a given lncRNA, we need to 
achieve high purification yields of a lncRNA complex because, unlike nucleic acids, we 
cannot amplify proteins prior to detection. (iii) Because any individual RNA is likely to be 
present at a very low percentage of the total cellular RNA, we need to achieve high levels of 
enrichment to identify specific interacting proteins. (iv) Because the number of background 
proteins will be high, even after enrichment, we need accurate and sensitive methods for 
protein quantification to detect specific lncRNA interacting proteins.
The RAP-MS method addresses these challenges because: (i) RAP uses long biotinylated 
antisense probes, which form very stable RNA-DNA hybrids, and therefore can be used to 
purify lncRNA complexes in denaturing and reducing conditions (ie. 4M urea at 67°C, 
Methods). (ii) We optimized the RAP method to achieve high yields of endogenous RNA 
complexes. In our original protocol13, we achieved <2% yield of the endogenous RNA 
complex; by optimizing hybridization, washing, and elution conditions (Methods), we were 
able to reproducibly achieve ~70% yield (Extended Data 1a, Methods). (iii) Using our 
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optimized conditions, we increased the enrichment levels for the target lncRNA complex 
(~5,000-fold, Extended Data 1b) relative to our already high levels of enrichment achieved 
previously (~100-fold)13. (iv) To achieve sensitive quantification and to distinguish between 
specific proteins and background proteins, we used Stable Isotope Labeling by Amino acids 
in Culture (SILAC) to label proteins (Methods, Extended Data 1c), which enables 
quantitative comparisons of purified proteins by mass spectrometry15.
We validated the RAP-MS approach by defining the proteins that interact with two well-
characterized non-coding RNAs: U1 (a core component of the spliceosome) and 18S (a 
component of the small ribosomal subunit). In the U1 purifications, we identified 9 enriched 
proteins, all of which are known to interact with U1 (Supplementary Note 1). In the 18S 
purification, we identified 105 enriched proteins, 98 of these (93%) were previously 
characterized as ribosomal proteins, ribosomal processing and assembly factors, 
translational regulators, or other known ribosome interactors (Extended Data 2). In 
particular, we identified 21 of the 31 known small ribosomal subunit proteins. The few 
missing proteins appear to fall predominately into two categories: (i) proteins that make few 
direct contacts with the RNA and (ii) small proteins that contain few peptides that could be 
detected by mass spectrometry.
These results demonstrate that the RAP-MS method identifies the majority of known RNA 
interacting proteins, and that the proteins identified by RAP-MS are highly specific for the 
purified ncRNA complex.
To define the proteins that interact with Xist during the initiation of XCI, we UV-
crosslinked SILAC-labeled mouse embryonic stem (ES) cells after Xist induction13 and 
purified Xist in nuclear extracts (Methods). To control for background proteins or non-
specific proteins that might interact with any nuclear RNA, we separately purified the 
abundant U1 snRNA, which is not expected to interact with the same proteins as Xist. We 
identified the proteins in each sample using liquid chromatography-mass spectrometry and 
calculated a SILAC ratio for each protein based on the intensity of all heavy or light 
peptides originating from the Xist or U1 purification (Figure 1a, Methods).
We identified 10 proteins that were enriched for Xist relative to U1 (SILAC ratio >3-fold, 
Figure 1b). All 10 proteins were reproducibly enriched in multiple Xist purifications from 
independent biological samples (Methods). Consistent with the notion that these proteins 
are direct Xist-interacting proteins, 9 proteins contain well-characterized RNA binding 
domains (Figure 1c).
The identified Xist-interacting proteins are SHARP, Rbm15, Myef2, Celf1, hnRNPC, LBR, 
SAF-A, Raly, hnRNPM, and Ptbp1 (Figure 1b). SAF-A (Scaffold Attachment Factor-A, also 
called hnRNPU) was previously shown to interact directly with Xist and is required for 
tethering Xist to the inactive X-chromosome in differentiated cells10. In addition, 5 of these 
proteins have been previously implicated in transcriptional repression, chromatin regulation, 
and nuclear organization. These include SHARP (SMRT and HDAC Associated Repressor 
Protein, also called SPEN), a member of the SPEN family of transcriptional repressors, 
which directly interacts with the SMRT component (also called NCoR-2) of the nuclear co-
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repressor complex16 that is known to interact with and activate HDAC3 deacetylation 
activity on chromatin7 (Figure 1c). Interestingly, we also identified RBM15, another 
member of the SPEN family of transcriptional repressors, which shares the same domain 
structure as SHARP, but appears to have a distinct functional role during development17. 
Myef2 has been shown to function as a negative regulator of transcription in multiple cell 
types, although its mechanism of regulation is still unknown18. hnRNPM is a paralog of 
Myef2. Finally, we identified LBR (Lamin B receptor), a protein that is anchored in the 
inner nuclear membrane and interacts with repressive chromatin regulatory proteins and 
Lamin B19 (Figure 1c).
We confirmed the specificity of the identified Xist-interacting proteins (Supplementary Note 
2, Methods): (i) To ensure that they are not due to non-specific RNA or protein capture, we 
performed RAP in uninduced cells (no Xist) and identified no enriched proteins. (ii) To 
ensure that these proteins are crosslinked with Xist in cells and not merely associating in 
solution, we performed RAP in cells that were not crosslinked (no UV) and identified no 
enriched proteins. (iii) To ensure that these proteins do not merely interact with any nuclear-
enriched long ncRNA, we compared the Xist-purified proteins to those purified with 45S 
(pre-ribosomal RNA) and found that all 10 Xist-interacting proteins were still enriched. (iv) 
To independently validate these interactions, we obtained high-quality affinity reagents for 8 
of the 10 proteins (Ptbp1, hnRNPC, Celf1, Myef2, Rbm15, LBR, Raly, and SHARP) and 
immunoprecipitated the identified proteins in UV-crosslinked lysates. In all cases, we 
observed a strong enrichment for the Xist RNA (>4-fold), but not control mRNAs or 
lncRNAs (Extended Data 3, Supplementary Table 1).
Together, these results identify a set of highly specific and reproducible proteins that 
directly interact with Xist during the initiation of XCI. Given the generality of the RAP-MS 
approach, we expect that it will be broadly applicable for defining the proteins that directly 
interact with other lncRNAs.
To determine which proteins are required for Xist-mediated transcriptional silencing, we 
knocked down each of the identified proteins and assayed for the failure to silence gene 
expression on the X-chromosome upon induction of Xist expression (Figure 2a).
Specifically, we selected two X-linked genes, Gpc4 and Atrx, that are well expressed in the 
absence of Xist expression, but are normally silenced by 16 hours of Xist induction in our 
doxycycline-inducible system in male cells (Figure 2b, Methods). We used siRNAs to 
knockdown the mRNA levels of each of the proteins identified by RAP-MS along with 
several negative controls (Methods, Supplementary Table 2). We ensured that each cell 
examined showed both successful depletion of the siRNA-targeted mRNA (>70% reduction) 
as well as induction of Xist expression using single molecule RNA FISH (Methods). Within 
each of these cells, we quantified the mRNA level of each of the two X-linked genes prior to 
Xist induction (−dox) and after Xist induction (+dox).
As a control, we transfected several non-targeting siRNAs (Methods). In these negative 
controls, we observed the expected silencing of the X-linked genes studied (Gpc4 expression 
decreased from an average of 20 copies (−dox) to 2 copies (+dox) per cell and Atrx 
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expression decreased from 22 to 3 copies per cell; Figure 2b,c). Consistent with previous 
observations, we found no effect on X-chromosome gene silencing upon knockdown of 
EED42,43, a required component of PRC220 (Figure 2b), or other proteins previously 
associated with Xist that do not appear to be required for transcriptional silencing (Extended 
Data 4, Methods). Similarly, knockdown of Rbm15, Myef2, Ptbp1, Celf1, hnRNPC, Raly, 
or hnRNPM did not alter gene silencing on the X-chromosome (Figure 2b, Extended Data 
5).
In contrast, knockdown of SHARP, LBR, or SAF-A largely abolished the silencing of X-
chromosome genes following Xist induction (Figure 2b,c, Supplementary Note 3, Extended 
Data 5, Extended Data 6). Indeed, the expression levels of the X-chromosome genes studied 
did not significantly change following Xist expression (Figure 2c, Extended Data 5). These 
same silencing defects were observed with several independent siRNAs (Extended Data 7). 
Importantly, we observed the same X-chromosome silencing defects upon knockdown of 
SHARP, LBR, or SAF-A in differentiating female ES cells (Extended Data 8, Methods).
These results demonstrate that SHARP, LBR, and SAF-A are required for Xist-mediated 
transcriptional silencing of the X-chromosome. Although the remaining seven Xist-
interacting proteins showed no effect on X-chromosome gene silencing, they may still be 
important for Xist function: (i) some may have redundant functions (e.g. Myef2 and 
hnRNPM, which are known paralogs), (ii) in some of these cases, the small amount of 
protein remaining after knockdown may still be sufficient for Xist function, or (iii) some of 
these proteins may be important for alternative Xist-mediated roles, such as the maintenance 
of XCI, which would not be captured by this silencing assay.
Xist initiates XCI by spreading across the future inactive X-chromosome, excluding RNA 
Polymerase II (PolII), and repositioning active genes into a transcriptionally silenced nuclear 
compartment3,10,13,21. All of these roles – localization, RNA PolII exclusion, and 
repositioning – are required for proper silencing of transcription during the initiation of 
XCI3.
Consistent with previous observations that SAF-A is required for Xist localization to 
chromatin in differentiated cells10, we observed a diffuse Xist localization pattern in the 
nucleus upon knock down of SAF-A (Extended Data 5). This suggests that SAF-A is 
required for transcriptional silencing by localizing Xist, and its silencing proteins, to the X-
chromosome during the initiation of XCI.
To determine the proteins responsible for establishing the initial silenced compartment on 
the X-chromosome, we explored whether SHARP or LBR are required for the exclusion of 
PolII from the Xist-coated region. Specifically, we measured the co-localization of Xist and 
PolII in single cells (Methods). In wild-type cells after 16 hours of Xist induction, we 
observed a depletion of PolII over the Xist-coated territory (Figure 3a, Methods). We 
observed a similar exclusion of PolII from the Xist-coated region in the negative controls 
and upon knockdown of EED or LBR (Figure 3a,b). In contrast, upon knockdown of 
SHARP, we observed higher levels of PolII over the Xist-coated territory relative to the 
control samples (Figure 3b). We confirmed that SHARP, but not LBR or EED, is similarly 
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required for PolII exclusion in differentiating female ES cells (Figure 3c, Extended Data 9, 
Supplementary Note 4).
These results demonstrate that SHARP is required to exclude PolII on the inactive X-
chromosome and may be required for creating the initial silenced compartment upon Xist 
localization3. While LBR is not required for PolII exclusion, it is likely to play an alternative 
role during the initiation of Xist-mediated transcriptional silencing, such as repositioning 
genes into this PolII-excluded compartment13,21.
Having identified SHARP as the direct Xist-interacting protein that is required for excluding 
PolII on the X-chromosome, we sought to determine how it might carry out this role. 
SHARP is a direct RNA binding protein6,22 that was first identified in mammals based on its 
interaction with the SMRT co-repressor complex6, which is known to interact with HDAC3 
and is required for activating its deacetylation and transcriptional silencing activity in vivo7. 
Based on these previous observations, we hypothesized that Xist-mediated transcriptional 
silencing through SHARP would occur through SMRT and the silencing function of 
HDAC3. (We would not expect to identify these proteins by RAP-MS, which was designed 
to identify only direct RNA-protein interactions.)
To test this hypothesis, we knocked down either SMRT or HDAC3 and measured the 
expression of X-chromosome genes upon Xist induction. Knockdown of SMRT or HDAC3 
in both male and female ES cells abrogated silencing of X-chromosome genes upon 
induction of Xist expression (Figure 2b, Extended Data 5, 7, and 8). To ensure that the 
observed silencing defect is specific for HDAC3 and not other class I HDAC proteins, we 
knocked down HDAC1 or HDAC2 and observed no effect on gene silencing (Extended Data 
5). To further confirm the specificity of our results, we used independent siRNAs to knock 
down SMRT or HDAC3 and in all cases identified a similar silencing defect (Extended Data 
7).
To determine whether this effect is similar to the effect produced by knock down of SHARP 
or a distinct defect in transcriptional silencing, we tested whether HDAC3, the silencing 
protein in this complex7,23, is required for the exclusion of RNA PolII from the Xist-coated 
territory. We found that knock down of HDAC3 in both male and female ES cells 
eliminated the exclusion of RNA PolII from the Xist-coated compartment to a similar degree 
to that seen for knock down of SHARP (Figure 3, Extended Data 9).
These results suggest that SHARP silences transcription through SMRT and the HDAC3 
silencing protein. This role for HDAC3 in Xist-mediated silencing would explain the long-
standing observation of global hypoacetylation on the entire X-chromosome as one of the 
very first events that occur upon initiation of XCI3,24.
One of the features of XCI is the recruitment of PRC2 and its associated H3K27me3 
repressive chromatin modifications across the X-chromosome in an Xist-dependent 
manner3,4,9. While PRC2 is not required for the initiation of XCI11,12 (Figure 3b), it or its 
associated H3K27me3 repressive chromatin modifications may be involved in establishing 
an epigenetically silenced state25. Yet, how Xist recruits the PRC2 complex across the X-
chromosome is unknown. Since we failed to identify any PRC2 components by RAP-MS, 
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and various HDAC complexes are known to recruit PRC226, we hypothesized that PRC2-
recruitment is mediated by SHARP and HDAC3.
To test this hypothesis, we looked at PRC2 recruitment to the Xist-coated territory. In wild-
type cells, we observe a strong enrichment of EZH2, a component of PRC2, over the Xist-
coated territory after 16 hours of induction (Figure 4a). Upon knock down of EED, a distinct 
component of the PRC2 complex that is required for its proper localization to chromatin20, 
we observe no enrichment of EZH2 over the Xist cloud at this same time point (Figure 4a). 
Similarly, upon knock down of SHARP, we identified a loss of EZH2 over the Xist coated 
territory, of comparable magnitude to that observed in the absence of EED (Figure 4a). 
Conversely, upon knock down of LBR, we observed a strong enrichment of EZH2 over the 
Xist coated territory, of comparable magnitude to the levels of recruitment in wild-type 
conditions (Figure 4b). To determine whether HDAC3 is required for PRC2 recruitment, we 
knocked down HDAC3 and observed a loss of PRC2 recruitment (Figure 4a), of comparable 
magnitude to that observed upon loss of SHARP (Figure 4b). Knockdown of SHARP or 
HDAC3 led to the same PRC2-recruitment defect in female ES cells (Figure 4c, Extended 
Data 10).
These results argue that Xist-mediated recruitment of PRC2 across the X-chromosome is 
dependent on SHARP and HDAC3. Whether this occurs through an interaction with SHARP 
or HDAC3 (direct recruitment) or due to the HDAC3-induced silenced transcription state, 
chromatin modifications, or compact chromatin structure (indirect recruitment) remains 
unclear (Supplementary Note 5). Yet, our results are in contrast to a previous model that 
PRC2 is recruited through a direct interaction between EZH2 and the A-repeat of Xist8. The 
evidence for this PRC2-Xist interaction is based on in vitro binding and purifications in non-
denaturing conditions8. Recently, the specificity of this interaction has been questioned 
because PRC2 appears to bind promiscuously to many RNAs, including bacterial RNAs, in 
these conditions27. Instead, our results are consistent with reports that deletion of the A-
repeat, unlike knockdown of SHARP or HDAC3, has no significant effect on PRC2 
recruitment to the Xist-coated territory9 (Figure 4b).
Taken together, our data suggest a model for how Xist can orchestrate transcriptional 
silencing on the X-chromosome (Figure 4d). Upon initiation of Xist expression, Xist can 
localize to sites on the X-chromosome by binding to the SAF-A protein10, which is known 
to interact directly with chromatin28. Xist directly interacts with SHARP to recruit SMRT6 
to these DNA sites across the inactive X-chromosome. This Xist-SHARP-SMRT complex 
either directly recruits HDAC3 to the X-chromosome or may act to induce the enzymatic 
activity of HDAC37 that may already be present at active genes across the X-chromosome29. 
Through HDAC3, Xist can direct the removal of activating histone acetylation marks on 
chromatin thereby compacting chromatin and silencing transcription30. Upon initiating the 
silenced state, Xist recruits PRC2 across the X-chromosome in an HDAC3-dependent 
manner, either through a direct interaction between PRC2 and HDAC3 or indirectly through 
HDAC3-induced transcriptional silencing or chromatin compaction (Supplemental Note 5). 
In this way, the same Xist interacting protein might achieve two essential roles in XCI – 
initiating the inactive state by recruiting transcriptional silencers (HDAC3) and maintaining 
the inactive state by recruiting stable epigenetic silencers (PRC2)25. Beyond Xist, RAP-MS 
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provides a critical tool that will accelerate the discovery of novel lncRNA mechanisms that 
have thus far proved elusive.
METHODS
Mouse ES cell culture
All mouse ES cell lines were cultured in serum-free 2i/LIF medium as previously 
described13. We used the following cell lines: (i) Wild-type male ES cells (V6.5 line); (ii) 
Male ES cells expressing Xist from the endogenous locus under control of a tet-inducible 
promoter (pSM33 ES cell line) as previously described13. (iii) Male ES cells carrying a 
cDNA Xist transgene without the A-repeat integrated into the Hprt locus under control of 
the tet-inducible promoter (A-repeat deletion: kindly provided by A. Wutz)31. (iv) Female 
ES cells (F1 2-1 line). This wild-type female mouse ES cell line is derived from a 129 × 
castaneous F1 mouse cross as previously described13.
Xist induction
For Dox inducible cells (pSM33 and A-repeat deletion), we induced Xist expression by 
treating cells with 2 µg/ml doxycycline (Sigma) for 6 hours, 16 hours, or 24 hours based on 
the application. For female ES cells (F1 2-1 line), we induced Xist expression by inducing 
differentiation; 2i was replaced with MEF media (DMEM, 10% Gemini Benchmark FBS, 
1× L-glutamine, 1× NEAA, 1× Pen/Strep; Life Technologies unless otherwise indicated) for 
24 hours followed by treatment with 1 µM retinoic acid (RA) (Sigma) for an additional 24 
hours.
We measured the amount of Xist RNA in both the doxycycline-inducible cells (6 hours 
induction) and differentiating female ES cells (24 hour induction) by qRT-PCR. We 
normalized this level to various RNA housekeeping controls, 18S, 28S, and U6, in both cell 
populations and calculated the fold expression difference between male and female cells 
using the comparative Ct method. We observed a range of expression, with the male 
inducible system expressing from 5–20 fold (12-fold average) more Xist than the female 
cells. We note that this estimate likely represents an upper limit of the actual differences 
because the female ES cell system is known to be heterogeneous in Xist-induction, such that 
not every cell will induce Xist to the same level after 24 hours of retinoic acid treatment. 
Accordingly, we expect that the actual differences between the male inducible system and 
differentiating female ES cells are actually significantly lower. While the precise levels are 
hard to compare by single molecule FISH, the size and intensity of each Xist RNA cloud is 
similar in both systems at the time points used.
The male-inducible system is more sensitive for identifying proteins that affect silencing 
compared to a female system because Xist-mediated silencing in males will lead to loss of 
100% of X-chromosome transcripts rather than only 50% in a female system, which still 
retains one active X.
McHugh et al. Page 8
Nature. Author manuscript; available in PMC 2015 November 14.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
UV crosslinking
Cells were washed once with PBS and then crosslinked on ice using 0.8 Joules/cm2 (UV8k) 
of UV at 254 nm in a Spectrolinker UV Crosslinker. Cells were then scraped from culture 
dishes, washed once with PBS, pelleted by centrifugation at 1500 × g for 4 minutes, and 
flash frozen in liquid nitrogen for storage at − 80 °C.
SILAC ES cell culture
For SILAC experiments, we adapted our ES cell culture procedures to incorporate either 
light or heavy lysine and arginine amino acids. The 2i/LIF SILAC medium was composed as 
follows: custom DMEM/F-12 without lysine or arginine (Dundee Cell Products) was 
supplemented with either 0.398 mM heavy Arg10 (Sigma) or unlabeled arginine (Sigma) 
and either 0.798 mM heavy Lys8 (Cambridge Isotope Labs) or unlabeled lysine (Sigma), 
0.5× B-27 (Gibco), 2 mg/mL bovine insulin (Sigma), 1.37 µg/mL progesterone (Sigma), 5 
mg/mL BSA Fraction V (Gibco), 0.1 mM 2-mercaptoethanol (Sigma), 5 ng/mL murine LIF 
(GlobalStem), 0.1 µM PD0325901 (SelleckChem) and 0.3 µM CHIR99021 (SelleckChem). 
Cells in both heavy and light 2i/LIF SILAC medium were also supplemented with 0.2 
mg/mL of unlabeled proline (Sigma) to prevent conversion of labeled arginine to proline. 2i 
inhibitors were added fresh with each medium change.
Adapting cells to SILAC conditions
Prior to mass spectrometry, ES cells were adapted to SILAC conditions over three passages. 
The heavy or light culture medium was replaced every 24–48 hours depending on cell 
density, and cells were passaged every 72 hours using 0.025% trypsin (Gibco), rinsing 
dissociated cells from the plates with DMEM/F12 containing 0.038% BSA Fraction V 
(Gibco). Cells were grown in two different types of medium: (i) 2i/LIF SILAC medium with 
light (unlabeled) lysine and arginine, or (ii) 2i/LIF SILAC medium with heavy isotope 
labeled lysine and arginine.
Measuring SILAC incorporation
To examine the efficiency of SILAC labeling in pSM33 cells, we tested for the 
incorporation of labeled amino acids after 10 days of growth (3 cell passages) in heavy 
2i/LIF SILAC medium. Pellets of 2 million cells were boiled for 10 minutes in LDS Sample 
Loading Buffer (Invitrogen) and then proteins were separated by SDS-PAGE on a 4–12% 
Tris-Glycine polyacrylamide gel (Invitrogen). Total protein was stained with Colloidal 
Coomassie (Invitrogen) and gel slices were excised with a clean scalpel and transferred to 
microcentrifuge tubes for in-gel tryptic digest. Protein disulfide bonds were reduced with 
DTT then alkylated with iodoacetamide. Proteins were digested with trypsin overnight and 
then extracted using successive washes with 1% formic acid/2% acetonitrile, 1:1 
acetonitrile/water, and 1% formic acid in acetonitrile. Peptides were collected, lyophilized, 
then resuspended in 1% formic acid for mass spectrometry analysis (described below in 
Mass Spectrum Measurements). Peptides were identified from mass spectra using 
MaxQuant (described below in MS data analysis). The incorporation rate of labeled amino 
acids was calculated based on the ratio of the intensity of heavy and light versions of each 
peptide identified. In cells used for subsequent assays, we confirmed that over 95% of 
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peptides from cellular proteins showed >95% incorporation of labeled amino acids 
(Extended Data 1b).
RNA Affinity Purification-Mass Spectrometry (RAP-MS)
Probe design and generation—To create the probes used to capture target RNAs, we 
designed and synthesized 90-mer DNA oligonucleotides (Eurofins Operon) that spanned the 
entire length of the target RNA. The sequence of each DNA oligonucleotide probes was 
antisense to the complementary target RNA sequence. Each DNA oligonucleotide probe was 
also modified with a 5’ biotin in order to enable capture of DNA-RNA hybrids on 
streptavidin coated magnetic beads (described below). While we had previously used 120-
mer probes, we found that 90-mer probes provided comparable stringency and yield in the 
conditions used. For Xist, we used 142 probes that covered the entire mature RNA sequence, 
with the exception of regions that match to other transcripts or genomic regions as 
previously described13,32.
Total cell lysate preparation—For the 18S and U1 experiments we used total cellular 
lysates prepared in the following manner. We lysed batches of 20 million cells by 
completely resuspending frozen cell pellets in ice cold detergent-based Cell Lysis Buffer (10 
mM Tris pH 7.5, 500 mM LiCl, 0.5% dodecyl maltoside (DDM, Sigma), 0.2% sodium 
dodecyl sulfate (SDS, Ambion), 0.1% sodium deoxycholate (Sigma)). Next, 1× Protease 
Inhibitor Cocktail (Set III, EDTA-free, Calbiochem) and 920 U of Murine RNase Inhibitor 
(New England Biolabs) were added and the sample was incubated for 10 minutes on ice to 
allow lysis to proceed. During this incubation period, the cell sample was passed 3–5× 
through a 26-gauge needle attached to a 1 mL syringe in order to disrupt the pellet and shear 
genomic DNA. Each sample was then sonicated using a Branson Digital Sonifier with a 
microtip set at 5 watts power for a total of 30 seconds in intermittent pulses (0.7 seconds on, 
1.3 seconds off). During sonication the samples were chilled to prevent overheating of the 
lysate. The samples were then treated for 10 minutes at 37 °C with 2.5 mM MgCl2, 0.5 mM 
CaCl2, and 20 U of TURBO DNase (Ambion) to digest DNA. Samples were returned to ice 
and the reaction was immediately terminated by the addition of 10 mM EDTA and 5 mM 
EGTA. Disulfide bonds were reduced by addition of 2.5 mM Tris-(2-carboxyethyl) 
phosphine (TCEP) and samples were then mixed with twice the lysate volume of 1.5× LiCl/
Urea Buffer (the final1 × Buffer contains 10 mM Tris pH 7.5, 5 mM EDTA, 500 mM LiCl, 
0.5% DDM, 0.2% SDS, 0.1% deoxycholate, 4M urea, 2.5 mM TCEP). Lysates were 
incubated on ice for 10 minutes then cleared by centrifugation in an Eppendorf 5424R 
centrifuge for 10 minutes at 16,000 × g. Supernatants were pooled and flash frozen in liquid 
nitrogen for storage at −80 °C.
Nuclear lysate preparation—For the Xist versus U1 and 45S versus U1 comparisons, 
we used nuclear lysates prepared in the following manner. We lysed batches of 50 million 
cells by resuspending frozen pellets in 1 mL Lysis Buffer 1 (10 mM HEPES pH7.2, 20 mM 
KCl, 1.5 mM MgCl2, 0.5 mM EDTA, 1 mM Tris(2-carboxyethyl)phosphine (TCEP), 0.5 
mM PMSF). Then the samples were centrifuged at 3,300 × g for 10 minutes to pellet cells. 
The cell pellets were resuspended in 1 mL Lysis Buffer 1 with 0.1% dodecyl maltoside 
(DDM) and dounced 20 times using a glass dounce homogenizer with the small clearance 
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pestle (Kontes). Nuclei released from the cells after douncing were pelleted by 
centrifugation at 3,300 × g then resuspended in 550 µl Lysis Buffer 2 (20 mM Tris pH 7.5, 
50 mM KCl, 1.5 mM MgCl2, 2 mM TCEP, 0.5 mM PMSF, 0.4% sodium deoxycholate, 1% 
DDM, and 0.1% N-lauroylsarcosine (NLS)). Samples were incubated on ice for 10 minutes, 
then each sample was sonicated using a Branson Sonifier at 5 watts power for a total of 1 
minute in intermittent pulses (0.7 seconds on, 3.3 seconds off) to lyse nuclei and solubilize 
chromatin. During sonication the samples were chilled to prevent overheating of the nuclear 
lysate. Samples were then treated with 2.5 mM MgCl2, 0.5 mM CaCl2, and 330 U TURBO 
DNase (Ambion) for 12 minutes at 37 °C to further solubilize chromatin. After DNase 
treatment, lysates were mixed with equal volume of 2× Hybridization Buffer (the final 1× 
Buffer contains 10 mM Tris pH 7.5, 5 mM EDTA, 500 mM LiCl, 0.5% DDM, 0.2% SDS, 
0.1% deoxycholate, 4M urea, 2.5 mM TCEP). Finally, lysates were cleared by 
centrifugation for 10 minutes at 16,000 × g in an Eppendorf 5424R centrifuge and the 
resulting supernatants were pooled and flash frozen in liquid nitrogen for storage at −80 °C.
RNA affinity purification of crosslinked complexes—Lysates from 200 million or 
800 million cells were used for each capture. For 200 million cells the following protocol 
was used, and scaled appropriately for larger cell numbers. For each capture, a sample of 
heavy or light SILAC labeled frozen lysate was warmed to 37 °C. For each sample, 1.2 mL 
of Streptavidin Dynabeads MyOne C1 magnetic beads (Invitrogen) were washed 6 times 
with equal volume of hybridization buffer (10 mM Tris pH 7.5, 5 mM EDTA, 500 mM 
LiCl, 0.5% DDM, 0.2% SDS, 0.1% deoxycholate, 4M urea, 2.5 mM TCEP). Lysate samples 
were pre-cleared by incubation with the washed Streptavidin C1 magnetic beads at 37 °C for 
30 minutes with intermittent shaking at 1100 rpm on a Eppendorf Thermomixer C (30 
seconds mixing, 30 seconds off). Streptavidin beads were then magnetically separated from 
lysate samples using a Dynamag magnet (Life Technologies). The beads used for pre-
clearing lysate were discarded and the lysate sample was transferred to fresh tubes twice to 
remove all traces of magnetic beads. Biotinylated 90-mer DNA oligonucleotide probes 
specific for the RNA target of interest (20 µg per sample, in water) were heat-denatured at 
85 °C for 3 minutes and then snap-cooled on ice. Probes and pre-cleared lysate were mixed 
and incubated at 67 °C using an Eppendorf thermomixer with intermittent shaking (30 
seconds shaking, 30 seconds off) for 2 hours to hybridize probes to the capture target RNA. 
Hybrids of biotinylated DNA probes and target RNA were then bound to streptavidin beads 
by incubating each sample with 1.2 mL of washed Streptavidin coated magnetic beads at 67 
°C for 30 minutes on an Eppendorf Thermomixer C with intermittent shaking as above. 
Beads with captured hybrids were washed 6 times with LiCl/Urea Hybridization Buffer at 
67 °C for 5 minutes to remove non-specifically associated proteins. Between 0.5 – 1% of the 
total beads were removed and transferred to a fresh tube after the final wash to examine 
RNA captures by qPCR (see “Elution and analysis of RNA samples”). The remaining beads 
were resuspended in Benzonase Elution Buffer (20 mM Tris pH 8.0, 2 mM MgCl2, 0.05% 
NLS, 0.5 mM TCEP) for subsequent processing of the protein samples.
Elution of protein samples—Elution of captured proteins from streptavidin beads was 
achieved by digesting all nucleic acids (both RNA and DNA, double-stranded and single-
stranded) using 125 U of Benzonase nonspecific RNA/DNA nuclease for 2 hours at 37 °C 
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(Millipore, #71206-3). Beads were then magnetically separated from the sample using a 
DynaMag magnet (Life Technologies) and the supernatant containing eluted Xist-specific 
proteins were precipitated overnight at 4 °C with 10% trichloroacetic acid (TCA). TCA 
treated protein elution samples were pelleted by centrifugation for 30 minutes at >20,000 × 
g, then washed with 1 mL cold acetone and recentrifuged. Final protein elution pellets were 
air dried to remove acetone and stored at − 20 °C until processing for mass spectrometry.
Elution and analysis of RNA samples—Beads with hybrids were magnetically 
separated using a 96-well DynaMag (Life Technologies) and the supernatant was discarded. 
Beads were then resuspended by pipetting in 20 µL NLS RNA Elution Buffer (20 mM Tris 
pH 8.0, 10 mM EDTA, 2% NLS, 2.5 mM TCEP). To release the target RNA, beads were 
heated for 2 minutes at 95 °C in an Eppendorf Thermomixer C. Beads were then 
magnetically separated using a 96-well DynaMag (Life Technologies) and the supernatants 
containing eluted target RNA were digested by the addition of 1 mg/mL Proteinase K for 1 
hour at 55 °C to remove all proteins. The remaining nucleic acids were then purified by 
ethanol precipitation onto SILANE beads (Invitrogen) as previously described13,32. DNA 
probes were removed by digestion with TURBO DNase (Ambion). To quantify RNA yield 
and enrichment, qPCR was performed as previously described13.
Mass Spectrometry Analysis
Preparation of proteins for mass spectrometry—Proteins from RAP-MS captures 
were resuspended in fresh 8 M urea dissolved in 40 µL of 100 mM Tris-HCl pH 8.5. 
Disulfide bonds were reduced by incubation with 3 mM TCEP for 20 minutes at room 
temperature, followed by alkylation with 11 mM iodoacetamide for 15 minutes at room 
temperature in the dark. Samples were then digested with 0.1 µg endoproteinase Lys-C for 4 
hours at room temperature. After Lys-C digestion the samples were diluted to a final 
concentration of 2M urea by the addition of 100 mM Tris-HCl pH 8.5, and CaCl2 was added 
to a final concentration of 1 mM. Tryptic peptides were generated by treatment with 0.1 to 
0.5 µg of trypsin overnight at room temperature. Contaminating detergents were removed 
from peptides using HiPPR detergent removal columns (Thermo), and peptides were 
protonated by the addition of 5% formic acid before desalting on a Microm Bioresources C8 
peptide MicroTrap column. Peptide fractions were collected and lyophilized, and dried 
peptides were resuspended in 0.2% formic acid with 5% acetonitrile.
Mass spectrum measurements—Liquid chromatography-mass spectrometry and data 
analyses of the digested samples were carried out as previously described33 with the 
following modifications. All experiments were performed on a nanoflow LC system, EASY-
nLC 1000 coupled to a hybrid linear ion trap Orbitrap Elite mass spectrometer (Thermo 
Fisher Scientific, Bremen, Germany) equipped with a nanoelectrospray ion source (Thermo 
Fisher Scientific). For the EASY-nLC II system, solvent A consisted of 97.8% H2O, 2% 
ACN, and 0.2% formic acid and solvent B consisted of 19.8% H2O, 80% ACN, and 0.2% 
formic acid. For the LC-MS/MS experiments, 200 ng of digested peptides were directly 
loaded at a flow rate of 500 nL/min onto a 16-cm analytical HPLC column (75 µm ID) 
packed in-house with ReproSil-Pur C18AQ 3 µm resin (120 Å pore size, Dr. Maisch, 
Ammerbuch, Germany). The column was enclosed in a column heater operating at 30°C. 
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After 30 min of loading time, the peptides were separated with a 75 min gradient at a flow 
rate of 350 nL/min. The gradient was as follows: 0–2% Solvent B (5 min), 2–30% B (60 
min), and 100% B (10 min). The Elite was operated in data-dependent acquisition mode to 
automatically alternate between a full scan (m/z=400–1600) in the Orbitrap and subsequent 
rapid 20 CID MS/MS scans in the linear ion trap. CID was performed with helium as 
collision gas at a normalized collision energy of 35% and 10 ms of activation time.
MS data analysis—Thermo RAW files were searched with MaxQuant (v 1.5.0.30)34,35. 
Spectra were searched against all UniProt mouse entries (43,565 entries, downloaded 02 Oct 
14) and MaxQuant contaminant database (245 entries). Decoy sequences (reversed peptide 
sequences) were generated in MaxQuant to estimate the false discovery rate36. Search 
parameters included multiplicity of 2 with heavy Arg (+10.0083) and heavy Lys (+8.0142) 
as heavy peptide modifications. Variable modifications included oxidation of Met 
(+15.9949) and protein N-terminal acetylation (+42.0106). Carboxyamidomethylation of 
Cys (+57.0215) was specified as a fixed modification. Protein and peptide false discovery 
rates were thresholded at 1%. Precursor mass tolerance was 7 ppm (or less for individual 
peptides). Fragment mass tolerance was 0.5 Da. Requantify and match between runs were 
both enabled. Trypsin was specified as the digestion enzyme with up to 2 missed cleavages.
Identification of RNA interacting proteins—Proteins of interest from RAP-MS 
captures were identified based on several criteria. First, proteins were considered identified 
only if 2 or more unique peptides were found in the mass spectrum. Then proteins of interest 
were selected based on the SILAC ratio of capture versus control samples. SILAC ratios for 
each peptide were calculated based on the intensity ratios of heavy and light SILAC pairs. 
The protein ratio is the median of all calculated peptide ratios, with a minimum of two 
SILAC pairs required for a SILAC ratio to be assigned to a given protein. A SILAC ratio 
cutoff of ≥3.0 (fold enrichment over control sample) was used as a cutoff for further 
analysis. We excluded known contaminants, including human keratin and proteins 
introduced during the sample purification and preparation process (such as streptavidin, 
Benzonase, and trypsin), as well as naturally biotinylated proteins that contaminate the 
preparation by binding to streptavidin beads.
RAP-MS experiments and controls
18S rRNA versus U1 snRNA—To validate the RAP-MS method and identify proteins 
specifically interacting with 18S ribosomal RNA or U1 snRNA, we performed captures of 
each target RNA in parallel samples from heavy and light labeled lysates from wild-type 
V6.5 ES cells. The total protein quantity in elution samples from each RAP-MS capture was 
measured by comparing the median intensity of peptides identified in a single quantitation 
MS run for each sample. The heavy and light label swapped samples were then mixed 
equally based on total protein quantity and analyzed by mass spectrometry to identify the 
SILAC enrichment ratio of proteins originating from 18S rRNA or U1 snRNA captures. The 
experiment was performed twice and each experimental set contained two biological 
replicates of 18S and U1 captures (heavy and light labeling states).
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Xist lncRNA versus U1 snRNA captures—To identify proteins specifically interacting 
with Xist lncRNA, we performed captures as described above with either 200M cells or 
800M pSM33 cells treated with doxycycline for 6 hours. The total protein quantity in elution 
samples from each RAP-MS capture was measured by a single quantitation MS run for each 
sample. Heavy and light label swapped samples were mixed equally based on total protein 
quantity, and analyzed by mass spectrometry. SILAC ratios of Xist enriched proteins versus 
U1 enriched proteins were calculated and used to identify Xist-specific interacting proteins 
for further analysis. The experiment was performed twice and each experimental set 
contained two biological replicates of Xist and U1 captures, from heavy and light labeled 
samples. Proteins replicated well between samples, with a sole exception (LBR) that was 
missed only because its enrichment level (2-fold) fell below our enrichment cutoff (3-fold) 
in some replicate samples.
Xist lncRNA capture from non-crosslinked cells—As a control to ensure that 
purified proteins are not non-specifically associated or binding in vitro with target RNAs 
during capture, we performed RAP-MS captures of Xist from non-crosslinked cells 
otherwise treated in the same manner (i.e. doxycycline treated for 6 hours).
Xist lncRNA capture from cells where Xist is not expressed—To confirm that the 
identified proteins are not resulting from background proteins or probe association with 
other RNAs or proteins in the pSM33 cells, we performed RAP captures of Xist from 
pSM33 cells that were not treated with doxycycline, but which were otherwise treated 
identically.
45S pre-rRNA capture versus U1 capture—To ensure that the proteins enriched in 
Xist captures using RAP-MS are not simply due to increased protein capture as a 
consequence of long target RNA transcripts, we additionally performed captures of the 
13,000 nucleotide long 45S pre-ribosomal RNA as a control. To ensure specific capture only 
of the 45S, and not the mature 18S and 28S, we designed probes that specifically targeted 
the internal transcribed spacer regions (ITS1 and ITS2) that are only present in the 45S pre-
ribosomal RNA. The experiment was performed in the same manner and with the same 
conditions as the Xist lncRNA captures described above. To compare Xist protein 
enrichment to 45S protein enrichment, we used a SILAC approach based on direct 
comparison of two samples that share a common denominator (called spike-in SILAC37). 
Specifically, we calculated an overall Xist/45S SILAC ratio by multiplying the Xist/U1 ratio 
by the U1/45S ratio for each identified protein.
Protein domain classification
We defined the conserved domain structures of proteins using the Protein Families database 
(Pfam38).
RNA Immunoprecipitation in UV-crosslinked cells
We crosslinked pSM33 cells after 6 hours of doxycycline-treatment with 0.4 Joules/cm2 of 
UV254. Cells were lysed and RNA was digested with RNase I to achieve a size range of 
100–500 nucleotides in length. Lysate preparations were precleared by mixing with Protein 
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G beads for 1 hour at 4 °C. For each sample, target proteins were immunoprecipitated from 
20 million cells with 10 µg of antibody (Supplementary Table 1) and 60 µl of Protein G 
magnetic beads (Invitrogen). The antibodies were pre-coupled to the beads for 1 hour at 
room temperature with mixing before incubating the precleared lysate to the antibody-bead 
complexes for 2 hours at 4 °C. After the immunoprecipitation, the beads were rinsed with a 
wash buffer of 1× PBS with detergents. After a dephosphorylation treatment, the RNA in 
each sample was ligated to a mixture of barcoded adapters in which each adapter had a 
unique barcode identifier. After ligation, beads were rinsed with 1× PBS and detergents and 
then 5× PBS (750 mM NaCl) and detergents prior to pooling 3–4 antibodies in a new tube. 
The proteins and RNA were then eluted from the Protein G beads with 6 M urea and 40 mM 
DTT at 60 °C. Protein-RNA complexes were separated away from free RNA by covalently 
coupling proteins to NHS-magnetic beads (Pierce) and washing 3 times in 6 M GuSCN 
(Qiagen RLT buffer) and heating in 1% NLS at 98 °C for 10 minutes. The proteins were 
then digested with Proteinase K and RNA was purified for subsequent analysis. From the 
barcoded RNA in each pool, we generated Illumina sequencing libraries as previously 
described32. We saved a small percentage (~1%) of starting material prior to 
immunoprecipitation and processed and sequenced this sample in parallel.
Analysis of crosslinked RNA Immunoprecipitation Data
We computed the enrichment for any RNA upon immunoprecipitation with a specific 
protein relative to its total levels in the cell. To do this, we counted the total number of reads 
overlapping the RNA in either the immunoprecipitation sample or the input control. To 
account for differences in read coverage between samples, each of these numbers was 
normalized to the total number of reads within the same experiment. This generates a 
normalized score, per RNA, within each sample. We then computed an enrichment metric 
by taking the ratio of these normalized values (IP/Input). We then compared these 
enrichment levels across different proteins and controls (i.e. IgG). To enable direct 
comparison across proteins for a given gene, we need to account for differences in the 
protein specific background level, which may occur to differences in IP efficiency or non-
specific binding of each antibody. To do this, we computed a normalized enrichment ratio 
by dividing the ratio for each gene by the average ratio across all genes for a given protein, 
as previously described1.
To exclude the possibility of promiscuous binding to all RNAs, we considered various 
mRNA controls, which are not expected to bind to these proteins, including Oct4, Nanog, 
Stat3, and Suz12. These mRNAs were selected as examples because they are expressed in 
ES cells, although many mRNAs show similar results. To account for the possibility that the 
Xist RNA non-specifically binds to any RBP, we evaluated Xist with other RBPs that we 
did not identify as interacting with Xist by RAP-MS (Pum1 and hnRNP-H). To ensure that a 
negative result (i.e. no enrichment for Xist) is meaningful and does not reflect a failed 
immunoprecipitation experiment, we evaluated Neat1-1, which we previously found 
immunoprecipitates with hnRNPH1. To further evaluate the level of enrichment on other 
lncRNAs, we considered several lncRNAs including Malat1, Firre, and Tug1. These 
lncRNAs were selected as examples because they are well-known and expressed in ES cells, 
although many ES lncRNAs show similar results.
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Immunoprecipitation and RT-qPCR
Female ES cells were differentiated then crosslinked with UV4k as described above. Pellets 
of 20M cells were lysed and treated with TURBO DNase (Ambion) to destroy DNA by 
incubation for 10 minutes at 37 °C in an Eppendorf Thermomixer C. The lysate was pre-
cleared by incubation with 180 µL of Dynabeads Protein G magnetic beads (Life 
Technologies). Meanwhile, 10 µg of antibody for immunoprecipitation (SHARP antibody, 
Novus NBP1-82952 or IgG antibody, Cell Signaling 2729S) was coupled to 60 µl Protein G 
magnetic beads. After pre-clearing was completed, the lysate was then mixed with the 
appropriate antibody-coupled Protein G magnetic beads and incubated for 2 hours at 4 °C on 
a Hulamixer sample mixer (Life Technologies) for protein capture. After 
immunoprecipitation, beads were washed with a wash buffer of 1× PBS with detergents and 
then captured nucleic acids were eluted by digesting all proteins with 5.6 U proteinase K 
(New England Biolabs). Eluted RNA was purified using the RNA Clean and Concentrator-5 
Kit (Zima Research) and RT-qPCR was performed as described previously13 to evaluate 
RNA enrichment.
V5-epitope tagged protein expression
For V5-tagged protein expression and immunoprecipitation, mouse ES cells were 
electroporated using the Neon transfection system (Invitrogen) with an episomally-
replicating vector (pCAG-GW-V5-Hygro) encoding expression of a C-terminal V5 tagged 
ORF driven by a CAG promoter. ORFs were obtained from the DNASU plasmid repository 
as Gateway entry clones and inserted into pCAG-GW-V5-Hygro using an LR recombination 
reaction (Invitrogen). Transfected cells were selected on 125ug/mL Hygromycin B 
(Invitrogen) to generate stably expressing lines.
siRNA Transfections
For siRNA knockdown experiments, 20 nM siRNAs were transfected using the Neon 
transfection system (settings: 1200V, 40ms width, 1 pulse). For each transfection, two 10 µL 
transfections with the same siRNA were carried out in succession using 100,000 cells each, 
mixed, and plated equally between two poly-L-lysine or poly-D-lysine (Sigma) and 0.2% 
gelatin (Sigma)-coated #1.5 coverslips placed into wells of a 24-well plate containing 2i 
media. After 48 hours, 2i media was replaced and cells on one coverslip of each pair were 
treated with 2 µg/mL doxycycline (Sigma) for 16hr to induce Xist expression. Coverslips 
were then fixed in Histochoice (Sigma) for 5 min, washed thoroughly in PBS, and 
dehydrated in ethanol for storage until FISH staining.
For all proteins we used siRNAs pool from Dharmacon (ON-TARGETplus SMARTpool 
siRNAs). For each of these, we tested whether the siRNA successfully reduced the targeted 
mRNA expression by >70%. For SAF-A and SMRT, the siRNAs failed to achieve this level 
of mRNA reduction, so we purchased additional siRNAs (and their associated controls) for 
SAF-A and SMRT from Qiagen and Ambion respectively, and selected siRNAs that 
successfully reduced on-target mRNA levels. siRNA against GFP was purchased from 
Qiagen. For additional independent siRNAs, the siRNAs were purchased as a pool from 
Dharmacon, Qiagen, and Ambion, or as each individual siRNA deconvoluted from the pool 
from Dharmacon and Qiagen (Supplementary Table 2).
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In addition to the proteins identified by RAP-MS, we knocked down several proteins 
previously reported to associate with Xist – including EED (a component of PRC2)8, 
YY139, Satb140, SRSF141, hnRNPC42, and Atrx43.
siRNA experiments in female ES cells
Female ES F1 2-1 cells were similarly transfected. To initiate differentiation and Xist 
expression for these cells, 2i was replaced with MEF media (DMEM, 10% Gemini 
Benchmark FBS, 1× L-glutamine, 1× NEAA, 1× Pen/Strep; Life Technologies unless 
otherwise indicated) at 12 hours post-transfection. Forty-eight hours after transfection, 1uM 
retinoic acid (Sigma) was administered for 24 hours and cells were fixed as described above. 
For cells not undergoing differentiation, 2i was replaced 12hr and 48hr after transfection.
Single molecule RNA FISH
Single molecule RNA Fluorescence in situ hybridization (FISH) experiments were done 
using QuantiGene ViewRNA ISH Cell Assay (Affymetrix) and QuantiGene ViewRNA ISH 
Cell 740 Module (Affymetrix) according to manufacturer’s protocol. Cells fixed on 
coverslips were first permeabilized with Detergent Solution QC at room temperature for 5 
min, and then incubated with desired mixture of probe set (Affymetrix) in Probe Set Diluent 
QF at 40°C for 3 h, followed by incubated with PreAmplifier Mix at 40°C for 30 min, 
Amplifier Mix at 40°C for 30 min, and Label Probe Mix at 40°C for 30 min sequentially. 
For DAPI staining, coverslips were incubated in 30 nM DAPI in PBS at room temperature 
for 15–20 min. Probe set and conjugated fluorophore for FISH were TYPE 1-XIST (550 
nm), TYPE 4-GPC4, RBMX, SMC1A, MECP2 (488 nm), TYPE 10-ATRX (740 nm), and 
TYPE 6-EED1, SHARP, LBR, SAFA, RBM15, MYEF2, PTBP1, HNRNPC, HNRNPM, 
CELF1, RALY, HDAC3, NCOR2, MID1, PIR (650 nm).
Immunofluorescence and RNA FISH
For immunofluorescence (IF), cells were fixed on coverslips and permeabilized with 0.1% 
Triton-X in PBS at room temperature for 10 min, and blocked with 5% normal goat serum in 
PBS at room temperature for 10 min. Cells were then incubated with primary antibodies at 
room temperature for 1 h, followed by incubating with secondary antibodies at room 
temperature for 1 h. The samples were then processed using the RNA FISH protocol, as 
described above. Primary antibodies and the dilution used for IF were anti-RNA polymerase 
II CTD repeat YSPTSPS (phospho S2) (Abcam; ab5095) (1:100), anti-Nanog (Abcam; 
ab80892) (1:100), and anti-EZH2 (Active Motif; 39933) (1:100). Secondary antibodies and 
the dilution used for IF were Alexa Fluor® 405 goat anti-rabbit IgG (H+L) (Life 
Technology; 1575534) (1:100) and Alexa Fluor® 488 F(ab’)2 fragment of goat anti-rabbit 
IgG (H+L) (Life Technology; 1618692) (1:100).
Microscopic Imaging
FISH and IF/FISH samples were imaged using a Leica DMI 6000 Deconvolution 
Microscope with the Leica HC PL APO 63×/1.30 GLYC CORR CS2 objective. Samples 
stained with TYPE 10-ATRX (740 nm) were imaged using Nikon Ti Eclipse with the Nikon 
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CFI Plan Apochromat λ DM 60×/1.40 oil objective. Images were projected with maximum 
projection (3 µm; step size, 0.5 µm).
X-chromosome Silencing Assay
Cells were stained for Xist RNA, Gpc4 mRNA, Atrx mRNA and siRNA-targeted mRNA by 
FISH and imaged. In addition, in some siScramble and siSHARP samples, we used probes 
against Rbm15, Mecp2, Smc1a, Mid1 or Pir mRNA. Images were then analyzed using 
Matlab R2013b (described below). Cells were selected if the copy number of the targeted 
mRNA was less than 30% of the level of the no siRNA treated cells and if they induced Xist 
expression. Within these cells, the copy number of Gpc4 mRNA and Atrx mRNA were 
quantified using a peak finding method (described below) and compared across conditions. 
We quantified mRNA levels for 50 individual cells. We also evaluated Xist expression in 
siRNA-treated cells, and observed no difference in the percentage of cells that induced Xist 
expression in any of the siRNA conditions relative to untreated cells.
Quantifying mRNAs by single molecule FISH
All image analysis was carried out using Matlab (version R2013b) utilizing built-in 
functions from the Image Processing toolbox. Images were first filtered using a two-
dimensional median filter to remove background. Cell boundaries were outlined manually, 
guided by DAPI staining, to create a binary mask and applied to the various channels from 
the same field of view. Top-hat morphological filtering, a background subtraction method 
that enhances the individual focal spots, was applied to the images44. The spots were then 
identified using a 2D peak finding algorithm that identifies local maximal signals within the 
cell. Once regional maxima were identified, the number of spots was counted for each cell.
Ezh2 Recruitment and PolII Exclusion
Cells were stained for Xist RNA and the siRNA-targeted mRNA (FISH) along with Ezh2 or 
PolII (IF) as described above. For image acquisition, the exposure time for each individual 
channel was kept the same across all samples. Images were then analyzed and selected for 
XIST-induced and cells showing knock down of the target mRNA, as described above. 
Specifically, the nuclei of individual cells were identified manually using the DAPI staining. 
We identified the Xist cloud by using an intensity-based threshold to partition the image 
within the nucleus and find contiguous 2-dimensional regions of high intensity. The 
threshold was determined based on Otsu method as previously described45, which splits the 
image into 2 bins – high and low – and identifies a threshold that minimizes the variance 
within the partition. This creates a binary mask on the image. We visually confirmed that 
this binary mask accurately reflected the Xist cloud. We then applied this binary mask to all 
other images in that field of view (PolII or Ezh2) for all images. We then quantified the 
intensity of fluorescence signal by taking the average intensity of all the pixels within the 
region (i.e. PolII or Ezh2, respectively). We computed this average intensity (1 number per 
cell) across all conditions and compared them using a 2-same unpaired t-test relative to the 
scramble sample across 50 single cells.
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Extended Data
Extended Data Figure 1. RAP-MS recovers and enriches the majority of Xist RNA from mouse 
ES cells, and these cells can be efficiently labeled with SILAC
(a) RT-qPCR measuring the percentage of the total cellular Xist or 18S recovered after 
RAP-MS of Xist. Values are computed as the amount of each RNA in the elution divided by 
the amount of RNA in the starting (“input”) lysate material. Error bars represent the standard 
error of the mean from 5 biological replicates. (b) Enrichment of Xist after RAP-MS 
captures from pSM33 cells as measured by qPCR. Bars indicate RNA levels of Xist, 18S, 
and Oct4 after purification of Xist, normalized to RNA in input sample. Each bar represents 
the RNA levels of Xist, 18S, and Oct4 after purification of Xist, normalized to RNA in input 
McHugh et al. Page 19
Nature. Author manuscript; available in PMC 2015 November 14.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
sample, from 3 biological replicates. (c) SILAC labeling efficiency of a representative 
culture of pSM33 mouse ES cells after 10 days of growth (3 cell passages) in SILAC 
medium. Peptides were analyzed by mass spectrometry, and values indicate the fraction of 
identified peptides with heavy-label incorporation with different levels of peptide labeling 
(shown in bins).
Extended Data Figure 2. RAP-MS identifies proteins that are known to directly interact with 
specific ncRNAs, and separates specific RNA interacting proteins from background proteins
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(a) SILAC ratios of top proteins enriched in the RAP-MS U1 snRNA, 18S rRNA, and 45S 
pre-rRNA experiments. (b) SILAC ratio plot of replicate captures of U1 snRNA versus 18S 
rRNA from one of two biologically independent label-swap experiments. Proteins associated 
with U1 are consistently found in U1 samples, both light and heavy labeled (top right 
quadrant), and proteins specifically associated with 18S are consistently identified in 18S, 
both light and heavy (lower left quadrant). Background contaminant proteins have low 
enrichments (center of panel) or are consistently found in the light channel and do not 
replicate between experiments (i.e. keratin, streptavidin). (c) SILAC ratio plot of replicate 
captures of U1 snRNA versus 45S pre-rRNA from one label-swap experiment. Proteins that 
are known to associate with 45S pre-rRNA are consistently identified in 45S captures.
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Extended Data Figure 3. Immunoprecipitation of the identified Xist-interacting proteins 
confirms Xist RNA interaction
RNA immunoprecipitation experiments were performed for seven Xist-interacting proteins 
(black bars), two control RNA binding proteins that were not identified by RAP-MS and 
IgG (gray bars) in UV-crosslinked cell lysate after 6 hours of Xist induction by doxycycline 
addition (Methods). The RNA associated with each protein was measured and enrichment 
levels were computed relative to the level of the RNA in total cellular input and normalized 
to the total efficiency of capture in each sample to allow for direct comparison across all IP 
experiments (Methods). (a) Enrichment of the Xist lncRNA after immunoprecipitation from 
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a sample of pSM33 male cells (b) Immunoprecipitation of SHARP was performed from a 
sample of UV-crosslinked females ES cells that were treated with retinoic acid for 24 hours. 
The levels of recovered Xist lncRNA (black bars), Neat1 lncRNA (white bars), and 45S pre-
ribosomal RNA (gray bars) were measured by RT-qPCR. Enrichment of each RNA after 
capture with anti-SHARP antibody was calculated relative to the level of RNA captured 
with IgG control antibody. (c) The enrichment of various lncRNAs after 
immunoprecipitation in pSM33 male cells – including Neat1, Malat1, Firre, and Tug1 – are 
shown. (d) The enrichment of various mRNA controls after immunoprecipitation in pSM33 
male cells – including Oct4, Nanog, Stat3, and Suz12 – are shown.
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Extended Data Figure 4. Previously identified proteins associated with XCI are not required for 
Xist-mediated transcriptional silencing
(a) To confirm the specificity of our assay, we tested the function of several proteins that 
were previously identified to associate with Xist, but not to silence transcription, for their 
role in transcriptional silencing in our inducible male ES cells prior to Xist induction (−Dox; 
left) or after Xist induction for 16 hours (+Dox; middle and right). Representative images 
are shown after knockdown of each protein – DAPI (blue), Xist (red), and Gpc4 (green). (b) 
Quantification of the copy number of Gpc4 before and after Xist induction upon treatment 
with different siRNAs. Error bars represent the standard error of the mean across 50 
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individual cells from one experiment. **** represents values with a p-value<0.001 between 
+Dox and −Dox cells based on an unpaired two-sample t-test. Scale bars on the images 
represent 5 µm. Importantly, while these proteins do not have a role in the initiation of 
transcriptional silencing, we do not mean to imply that they do not have other roles in XCI.
Extended Data Figure 5. SHARP, LBR, SAF-A, SMRT, and HDAC3 are required for Xist-
mediated transcriptional silencing
(a) Representative images showing staining of DAPI (blue), Xist (red), and Gpc4 (green) for 
different siRNA knockdown in male ES cells prior to Xist induction (−Dox; left) or after 
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Xist induction for 16 hours (+Dox; middle and right). (b) Quantification of the copy number 
of Gpc4 in −Dox and +Dox cells after knockdown with siRNAs targeting different mRNAs. 
Error bars represent the standard error of the mean across 50 individual cells from one 
experiment. NS: not significantly different between +Dox and −Dox cells; **** represents 
values with a p-value<0.001 between +Dox and –Dox cells based on an unpaired two-
sample t-test. Scale bars on the images represent 5 µm. (c) Knockdown of SHARP, LBR, or 
SAF-A abrogates Xist-mediated gene silencing without causing pluripotency defects. 
Representative images showing staining of Nanog (cyan), Xist (red), and Gpc4 (green) upon 
knockdown of SHARP, LBR or SAF-A after 16 hours of Xist induction with doxycycline. 
Scale bars on the images represent 5 µm.
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Extended Data Figure 6. SHARP is required for silencing many genes across the X-chromosome
(a) A diagram showing the locations of Xist (red), X-linked silenced genes (black), and X-
linked escaped genes (green) along the X-chromosome. (b) Representative images showing 
staining of DAPI (blue), Xist (red), X-linked silenced genes (green), and X-linked escaped 
genes (yellow) upon knockdown of SHARP or control male ES cells prior to Xist induction 
(−Dox) or after Xist induction for 16 hours (+Dox). Knock of SHARP abolishes the 
silencing of Atrx, Gpc4, Rbmx, Smc1a and Mecp2, which are normally silenced upon Xist 
expression, but has no effect on Mid1 and Pir, which normally escape Xist-mediated 
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silencing. The bar graphs show the quantification of the copy number of the mRNA for each 
gene for −Dox and +Dox cells upon transfection with SHARP siRNA or control siRNA; 
Error bars represent the standard error of the mean across 50 individual cells from one 
experiment, NS: not significantly different, **** represents values with a p-value<0.001, 
and ** represents values with a p-value<0.01 between +Dox and −Dox cells based on an 
unpaired two-sample t-test. Scale bars on the images represent 5 µm.
Extended Data Figure 7. Multiple independent siRNAs targeting SHARP, LBR, SAF-A, HDAC3, 
or SMRT demonstrate the same silencing defect
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(a) Representative images showing staining of DAPI (blue), Xist (red), and Gpc4 (green) 
after knockdown of proteins using independent, non-overlapping, siRNA pools, or 
individual siRNA deconvoluted from the pool prior to Xist induction (−Dox; left) or after 
Xist induction for 16 hours (+Dox; middle and right). Cells were either transfected with the 
siRNA pool from Dharmacon (siRNA-D), Qiagen (siRNA-Q) or Ambion/Life Technologies 
(siRNA-A), or each individual siRNA deconvoluted from the pool from Dharmacon 
(siRNA-D1, 2, 3, 4) or Qiagen (siRNA-Q1, 2, 3, 4). Error bars represent the standard error 
of the mean across 50 individual cells from one experiment. NS: not significantly different 
between +Dox and −Dox cells based on an unpaired two-sample t-test. Scale bars on the 
images represent 5 µm. We excluded all siRNAs that did not reduce the targeted mRNA 
level by >70% (Methods). The sequences of deconvoluted siRNAs are shown in 
Supplementary Table 2.
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Extended Data Figure 8. SHARP, LBR, SAF-A, SMRT, and HDAC3 are required for 
transcriptional silencing in differentiating female ES cells
(a) Representative images showing staining of DAPI (blue), Xist (red), and Gpc4 (green) 
upon knockdown of specific proteins using different siRNAs in female ES cells prior to 
differentiation (−RA; left) or after differentiation for 24 hours (+RA; middle and right). (b) 
Quantification of the copy number of Gpc4 for −RA and +RA cells upon transfection with 
different siRNAs. Error bars represent the standard error across 50 individual cells from one 
experiment. NS: not significantly different between +RA and −RA cells; **** represents 
values with a p-value<0.001, ** represents values with a p-value<0.01, and * represents 
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values with a p-value<0.05 between +RA and −RA cells based on an unpaired two-sample t-
test. Scale bars on the images represent 5 µm.
Extended Data Figure 9. SHARP is required for exclusion of RNA Polymerase II from the Xist-
coated territory in differentiating female ES cells
Images of individual cells that are labeled with Xist (red), RNA Polymerase II (green), and 
DAPI (blue) across different siRNA conditions (rows) in female ES cells after 24 hours of 
retinoic acid treatment. The dashed white region represents the outlined Xist coated 
territory.
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Extended Data Figure 10. SHARP is required for PRC2 recruitment across the Xist coated 
territory in differentiating female ES cells
Images of individual cells that are labeled with Xist (red), Ezh2 (green) and DAPI (blue) 
across different siRNA conditions (rows) in female ES cells after 24 hours of differentiation. 
The dashed white region represents the outlined Xist coated territory.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. RAP-MS identifies direct Xist-interacting proteins
(a) A schematic overview of the RAP-MS method. (b) The SILAC ratio (Xist/U1) for each 
Xist-enriched protein identified by RAP-MS for one representative sample of four biological 
replicates. For SHARP and RBM15, the enrichment values are indicated above their bars. 
(c) Each Xist-interacting protein is shown (scaled to protein length). The locations of 
functional domains are shown.
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Figure 2. SHARP, LBR, and SAF-A are required for Xist-mediated gene silencing
(a) Screen for Xist-mediated gene silencing for knockdown of control (top), non-silencing 
proteins (middle), or silencing proteins (bottom). (b) Gpc4 mRNA levels after induction of 
Xist (+dox) normalized to Gpc4 levels before Xist induction (−dox). Error bars: standard 
error of the mean across 50 cells from one experiment. siCtrl: scrambled siRNA control. (c) 
Images of individual cells for two X-linked mRNAs, Gpc4 (green) and Atrx (red), and DAPI 
(blue) after treatment with different siRNAs (rows). The number of identified mRNAs is 
shown. Scale bars, 5 micrometers.
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Figure 3. SHARP is required for exclusion of PolII from the Xist-coated territory
(a) Xist (red), PolII (green), and DAPI (blue) across different siRNA conditions (rows). 
Quantification of fluorescence intensity of PolII within Xist territory normalized to control 
siRNA levels for (b) male ES cells after 16 hours of doxycycline treatment and (c) female 
ES cells after 1 day of retinoic acid induced differentiation. Error bars: standard error of the 
mean across 50 cells from one experiment. NS: not significant, **** p-value<0.001 relative 
to siControl by unpaired two-sample t-test. ΔA: Genetic deletion of A-repeat. Scale bars, 5 
micrometers.
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Figure 4. SHARP is required for PRC2 recruitment across the Xist-coated territory
(a) Xist (red), Ezh2 (green) and DAPI (blue) across siRNA conditions (rows). Quantification 
of Ezh2 levels within the defined Xist territory normalized to the levels in the control siRNA 
sample for (b) male ES cells and (c) differentiating female ES cells. Error bars: standard 
error of the mean across 50 cells from one experiment. NS: not significant, ***, p-
value<0.005, **** p-value<0.001 relative to siControl by an unpaired two-sample t-test. 
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Scale bars, 5 micrometers. (d) A model for Xist-mediated transcriptional silencing and 
recruitment of PRC2 across the X-chromosome.
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